Clinical Trial Update: Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the effects of green tea and fermented papaya preparation on diabetes and cardiovascular risk markers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Diabetes Mellitus

Drugs mentioned

• Fermented Papaya Preparation
• Green tea

Snippet

Sponsor: The Touro College and University System | Conditions: Assess the Effect of Green Tea on Diabetes, Assess the Effect of Fermented Papaya Pretration on Diabetes | Phase 2, Phase 3 | Status: COMPLETED